About Sofomax 400 mg Tablet
Sofomax 400 mg tablets are made by Advanced Chemical Industries PLC and contain the generic sofosbuvir. It is an antiviral medicine used as part of combination treatment for chronic hepatitis C infection, and it is taken only under a doctor's supervision.
There are 2 brands of Sofosbuvir listed in Bangladesh. 1 of them has a lower unit price than Sofomax. The lowest listed price is Buviren 400 mg Tablet at ৳ 600.00 per unit.
What is Sofomax 400 mg Tablet?
Sofomax is a 400 mg tablet from Advanced Chemical Industries PLC. Its active ingredient is sofosbuvir, an antiviral that belongs to the hepatitis C treatment group. It works by blocking the virus from copying itself, and it is always given together with other antiviral medicines rather than alone. It is used for long-term (chronic) hepatitis C infection in adults. Because the combination and course depend on the person's situation, the doctor decides how it is used. Ask the doctor or pharmacist about anything unclear.
Uses of Sofomax
Sofomax is used to treat chronic hepatitis C infection in adults. It is given as one part of a combination antiviral regimen, not by itself. Studies of sofosbuvir have covered several hepatitis C genotypes, including some people with related liver cancer. Whether it suits a particular person, and which other medicines are combined with it, is decided by the doctor after tests and assessment.
How to use Sofomax
Sofomax is a tablet that is swallowed, with or without food. It is taken together with other antiviral medicines as part of a combination regimen. The doctor decides the dose, the partner medicines and how long the course lasts; do not change these yourself. If you miss a tablet or are unsure about timing, ask your doctor or pharmacist for advice rather than adjusting it on your own.
Side effects of Sofomax
When sofosbuvir is combined with ribavirin, the most common side effects reported are fatigue and headache. When it is combined with peginterferon alfa and ribavirin, common effects include fatigue, headache, nausea, trouble sleeping, anaemia, itching, rash, poor appetite, chills, fever, diarrhoea, muscle pain and irritability. Tell your doctor if any side effect bothers you or does not settle.
Safety and precautions
Sofosbuvir is combined with other antiviral medicines, and the warnings that apply to those partner medicines also apply here. Such combinations are not for women who are pregnant or may become pregnant, or men whose partners are pregnant, because of ribavirin-related risks. Whether sofosbuvir is suitable in pregnancy or breastfeeding is not well established, so ask the doctor first. Serious slow heartbeat can occur if amiodarone is taken alongside, so tell your doctor about all your medicines. Ask the doctor before starting if you have heart or liver problems.
Frequently asked questions
What kind of medicine is Sofomax and what is it used for?
Sofomax is an antiviral tablet containing sofosbuvir. It is used to treat chronic hepatitis C infection in adults, always as part of a combination treatment plan chosen by the doctor rather than on its own.
Who should avoid Sofomax or check with the doctor first?
People taking amiodarone, or with heart or liver problems, should speak to the doctor before use, as should anyone taking other medicines. Pregnancy and breastfeeding need a doctor's advice, and the warnings for the partner medicines also apply.
What does the generic name sofosbuvir mean?
Sofosbuvir is the generic name of the active ingredient. It is a nucleotide analogue that blocks a hepatitis C virus enzyme needed for the virus to copy itself, which is how it helps suppress the infection as part of combination therapy.
Can Sofomax be taken alone?
No, it is used together with other antiviral medicines as a combination regimen. The doctor decides which medicines are combined with it and for how long, based on tests and the person's condition.
- Strength
- 400 mg
Price in Bangladesh
৳ 700 unit price
Price updated: 16 Nov 2026
Indications
Sofosbuvir is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
Sofosbuvir efficacy has been established in subjects with HCV genotype 1, 2, ... Read moreSofosbuvir is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
Sofosbuvir efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection.
The following points should be considered when initiating treatment with Sofosbuvir:
- Monotherapy of Sofosbuvir is not recommended for treatment of CHC.
- Treatment regimen and duration are dependent on both viral genotype and patient population.
- Treatment response varies based on baseline host and viral factor.
Pharmacology
Sofosbuvir is nucleotide analog inhibitor, which specifically inhibits HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Following intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), sofosbuvir incorporates into HCV RNA by the NS5B polymerase and acts as a chain terminator. More specifically, Sofosbuvir prevents HCV viral replication by binding to the two Mg2+ ions present in HCV NS5B polymerase's GDD active site motif and preventing further replication of HCV genetic material
Dosage & Administration
One 400 mg tablet taken once daily with or without food. Should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC.
Recommended combination therapy: (HCV Mono-infected and HCV/HIV-1 Co-infected)-
- Genotype 1 or 4: Sofosbuvir + Peginterferon alfa + Ribavirin for 12 weeks
- Genotype 2: Sofosbuvir + Ribavirin for 12 weeks
- Genotype 3: Sofosbuvir + Ribavirin for 24 weeks
Sofosbuvir in combination with Ribavirin for 24 weeks can be considered for CHC patients with genotype 1 infection who are Interferon ineligible
Should be used in combination with Ribavirin for treatment of CHC in patients with hepatocellular carcinoma awaiting liver transplantation for up to 48 weeks or until liver transplantation whichever occurs first
A dose recommendation cannot be made for patients with severe renal impairment or end stage renal disease
Interaction
Reduced therapeutic effect with drugs that are potent P-gp inducers in the intestine (eg rifampicin, St. John's wort, carbamazepine & phenytoin), modafinil, phenobarb/ oxcarbazepine, rifabutin/ rifapentine. P-gp &/or BCRP inhibitors. May result in serious symptomatic bradycardia when co-administered with amiodarone in combination with another direct acting antiviral.
Contraindications
When Sofosbivur is used in combination with Ribavirin or Peginterferon alfa/ Ribavirin, the contraindications applicable to those agents are applicable to combination therapies. Sofosbuvir combination treatment with Ribavirin or Peginterferon alfa/Ribavirin is contraindicated in women who are pregnant or may become pregnant and men whose female partners are pregnant, because of the risks for birth defects and fetal death associated with Ribavirin.
Side Effects
The most common adverse events (incidence greater than or equal to 20%, all grades) observed with Sofosbuvir in combination with Ribavirin were fatigue and headache. The most common adverse events observed with Sofosbuvir in combination with Peginterferon alfa and Ribavirin were fatigue, headache, nausea, insomnia, anemia, pruritus, asthenia, rash, decreased appetite, chills, influenza like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability.
Pregnancy & Lactation
Pregnancy Category B: Sofosbuvir There are no adequate and well-controlled studies with Sofosbuvir in pregnant women.
Nursing Mothers: It is not known whether Sofosbuvir and its metabolites are present in human breast milk.
Precautions & Warnings
Bradycardia with amiodarone co-administration: Serious symptomatic bradycardia may occur in patients taking amiodarone and Sofosbuvir in combination with another direct acting antiviral (DAA), particularly in patients also receiving beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease. Co-administration of amiodarone with Sofosbuvir in combination with another DAA is not recommended. In patients without alternative, viable treatment options, cardiac monitoring is recommended.
Overdose Effects
The highest dose of Sofosbuvir is a single dose of Sofosbuvir 1200 mg. No specific antidote is available for overdose treatment. Treatment of overdose with Sofosbuvir consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient.
Storage Conditions
Keep out of the reach of children. Keep in a cool & dry place. Protect from light.
Alternative brands of Sofosbuvir
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.